Global Tissue Regeneration Market, By Technology (Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Tissue Vascularization, Cell Culturing and Others), Raw Material (Synthetic, Genetically modified and Biological), Application (Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Ophthalmology and Others), End-User (Hospital & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Others) – Industry Trends and Forecast to 2029
Market Analysis and Size
Congenital illnesses, malformations, and disease-related tissue damage drive the demand for tissue regeneration. This factor is expected to shape the future trajectory of the global tissue regeneration market in the coming years. Tissue engineering is essentially a procedure for controlling, repairing, and improving the function of injured tissue. The tissue regeneration technique increases a patient's life expectancy by repairing diseased or damaged organs, such as the kidneys. Regenerative medicine has the potential to address the current organ donor shortage; for example, tissue reengineered skin is extremely useful for foot and leg ulcers, burn wounds, and skin replacement.
Data Bridge Market Research analyses that the tissue regeneration market is expected to reach the value of USD 482.95 billion by the year 2029, at a CAGR of 25.44% during the forecast period. The growing demand for personalised medicines will aid in the expansion of the tissue regeneration market.
Tissue regeneration is the process of restoring or repairing damaged or diseased tissue by regrowing or replacing it. Congenital diseases, defects, and tissue damage caused by diseases promote the need for tissue regeneration. This technique includes a tissue engineering procedure that manages, restores, and improves the application of damaged tissue. The tissue regeneration procedure increases patients' life expectancy by restoring damaged organs, including the kidneys. Regenerative medicine has the potential to end the current shortage of organ donors; for example, tissue reengineered skin is extremely beneficial for skin replacement, burn wounds, and ulcers that affect the leg and foot.
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million, Volumes in Units, Pricing in USD
Technology (Cell Therapy, Stem Cell Therapy, Stem Cell Sources, Tissue Vascularization, Cell Culturing and Others), Raw Material (Synthetic, Genetically modified and Biological), Application (Cardiovascular, Oncology, Dermatology, Orthopedic, Neurology, Ophthalmology and Others), End-User (Hospital & Diagnostic Centres, Pharmaceutical & Biotechnology Companies, Contract Research Organizations and Others
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
Arteriocyte Medical Systems Inc. (U.S.), Athersys Inc. (U.S.), Cerapedics Inc. (U.S.), Co. Don AG (Germany), Cook Medical Inc. (U.S.), U.S. Stem Cell Inc. (U.S.), Cytori Therapeutics, Inc. (U.S.A), Cerapedicsm, Inc. (U.S.), Organogenesis, Inc. (U.S.), Wright Medical Group N.V. (Netherlands), Zimmer Biomet (U.S), ACell, Inc. (U.S.), Tissue Regenix (U.S.)
Tissue regeneration Market Dynamics
- The rise in the use biomarkers
The rising prevalence of chronic diseases, the use of biomarkers in disease diagnosis, the need for personalised medicines, and government grants and investments around the world are expected to drive the growth of the tissue regeneration market.
The increase in the use of 3d printing functions
The expansion of 3D printing functions in tissue regeneration, as a result of research and development and invention in biomaterials, nanotechnology, cell therapies, and drug delivery, is expected to amplify the growth of the tissue regeneration market during the forecast period.
Maintaining compliance with medical reforms and regulations raises the demand for these solutions.
- Government investments for healthcare interoperability
The increase in the funding by the federal government to drive the adoption of these solutions further influence the market. Additionally, the surge in healthcare expenditure, advancements in healthcare infrastructure, and high demand for expanded care delivery positively affect the tissue regeneration market.
Strict government administrations, repayment concerns, particularly in emerging nations, and less funding in developing countries are the factors most likely to stymie the growth of the tissue regeneration market.
This tissue regeneration market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tissue regeneration market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Tissue Regeneration Market
The pandemic of COVID-19 has had a significant impact on the health-care industry. Since the COVID 19 pandemic, clinical tissue engineering research has been made unavailable, and non-COVID 19 clinical trials have been reduced. In the meantime, several pharmaceutical and biotech companies have shifted their focus to the development of COVID-19 treatment drugs and vaccines. Furthermore, a significant decrease in cell and tissue donation programmes has restrained the global tissue engineering market. As a result, clinical research delays and disruptions, as well as cancellations or delays in tissue replacement and reconstructive procedures, impede the global tissue engineering market's growth.
- The United States Department of Health launched the "New Vision" initiative in 2020 with the goal of bringing regenerative medicine and stem cell therapy to the forefront of healthcare.
- Tissue Regeneration Technologies (TRT) announced an important addition to our patent family in April 2020, which could aid in the fight against the Coronavirus. This patent employs the well-known mechanisms of action of unfocused shockwaves to combat this lethal virus.
- ACell received an additional 510(k) FDA clearance for its Gentrix product line in April 2019. As a result, the indications for using the company's Gentrix surgical matrix products grew.
Global Tissue Regeneration Market Scope
The tissue regeneration market is segmented on the basis technology, raw material, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Cell therapy
- Stem cell therapy
- Stem cell sources
- Tissue vascularization
- Cell culturing
Based on the technology, the tissue regeneration market is segmented into cell therapy, stem cell therapy, stem cell sources, tissue vascularization, cell culturing and others.
- Genetically modified
Based on the raw material, the tissue regeneration market is segmented into synthetic, genetically modified and biological.
Based on the application, the tissue regeneration market is segmented into cardiovascular, oncology, dermatology, orthopaedic, neurology, ophthalmology and others.
- Pharmaceutical biotechnology
- Contract research organizations
- Hospitals and diagnostics centres
Based on the end-user, the tissue regeneration market is segmented into hospital and diagnostic centres, pharmaceutical and biotechnology companies, contract research organizations and others.
Tissue Regeneration Market Regional Analysis/Insights
The tissue regeneration market is analysed and market size insights and trends are provided by country, technology, raw material, application and end-user as referenced above.
The countries covered in the tissue regeneration market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the tissue regeneration market due to an ageing population and the availability of developed healthcare equipment. Factors such as an increase in the number of clinical trials to estimate product therapeutic potential, an increase in the incidence of chronic diseases, and an increase in public awareness of therapy's therapeutic potency are all driving the growth of the tissue regeneration market in the region. Europe is expected to see significant growth in the tissue regeneration market as a result of factors such as the easy availability of funds for R&D and the government's increasing support for the life science domain, which will further propel growth.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The tissue regeneration market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tissue regeneration market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tissue regeneration market. The data is available for historic period 2010-2020.
Competitive Landscape and Tissue Regeneration Market Share Analysis
The tissue regeneration market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tissue regeneration market.
Some of the major players operating in the tissue regeneration market are
- Arteriocyte Medical Systems Inc. (U.S.)
- Athersys Inc. (U.S.)
- Cerapedics Inc. (U.S.)
- Co. Don AG (Germany)
- Cook Medical Inc. (U.S.)
- U.S. Stem Cell Inc. (U.S.)
- Cytori Therapeutics, Inc. (U.S.A)
- Cerapedicsm, Inc. (U.S.)
- Organogenesis, Inc. (U.S.)
- Wright Medical Group N.V. (Netherlands)
- Zimmer Biomet (U.S)
- ACell, Inc. (U.S.)
- Tissue Regenix (U.S.)